Cellular genes capable of inducing oncogenic transformation have recently been identified by transfection of DNAs of both normal and neoplastic cells (1) (2) (3) (4) (5) . The low efficiency of transformation (=0.003 transformant per ,tg of DNA) induced by DNA fragments of normal cells appears to represent activation of normal cell genes with potential transforming activity, because cells transformed by normal cell DNA fragments contain activated transforming genes that can be transmitted at high efficiencies (0.1-1 transformant per ,ug of DNA) in secondary transfection assays (1) . Activated transforming genes that can be efficiently transmitted by transfection with high molecular weight DNAs have also been found in chemically transformed mouse fibroblasts (2) , lymphomas and a nephroblastoma induced by avian lymphoid leukosis viruses (3) , and human bladder carcinomas (4, 5) . The transforming genes detected by transfection of DNAs of tumors induced by lymphoid leukosis viruses, a class of weakly oncogenic retroviruses that lack viral transforming genes, are not linked to viral DNA sequences, suggesting that oncogenesis by these viruses involves indirect activation ofcellular transforming genes (3) . These findings thus suggest that transformation by a variety of carcinogenic agents can involve dominant mutations or gene rearrangements resulting in the activation of cellular transforming genes, which are then detectable by transfection.
In the present study, we have investigated the transforming activities of DNAs of mouse mammary carcinomas, induced by either mouse mammary tumor virus (MMTV) or dimethylbenzanthracene (DMBA), and of a human mammary carcinoma cell line. MMTV is a weakly oncogenic retrovirus that, like the avian lymphoid leukosis viruses, does not appear to contain viral transforming genes. Endogenous MMTV genomes are normally present in DNAs of most mice, but oncogenesis by MMTV appears to be dependent upon exogenous virus infection (6) (7) (8) (9) (10) . In C3H mice, mammary tumors occur with high frequency as a consequence of exogenous infection by milk-transmitted MMTV (6, 7) . Other strains of mice, such as BALB/c, do not transmit infectious exogenous MMTV and have a much lower incidence of spontaneous mammary carcinomas (6, 7) .
High molecular weight DNAs of five MMTV-induced C3H mammary carcinomas, one DMBA-induced BALB/c mammary carcinoma, and the human mammary carcinoma cell line MCF-7 induced efficient transformation of NIH 3T3 cells, indicating that these mouse and human mammary carcinomas contained activated transforming genes. As in the case of neoplasms induced by avian lymphoid leukosis virus (3), the transforming genes of MMTV-induced tumors were not linked to viral DNA sequences. Analysis ofthe transforming activities ofthese tumor DNAs by digestion with restriction endonucleases indicated that the same or closely related transforming genes were activated in each of the six mouse mammary carcinomas and in the human mammary carcinoma cell line.
MATERIALS AND METHODS
Tumor and Cell Lines. MMTV-induced mammary tumors were obtained from C3H/HeSFCI nu/+ retired breeder females. The SFCI colony was established 3 years ago with C3H/ HeN nu/+ females and C3H/HeN nu/nu males obtained from K. Hansen (National Cancer Institute). Tumor incidence is 100% in multiparous females and average age at tumor onset is 7.5 months. Normal mammary glands were obtained from tumor-free multiparous females 2 weeks after lactation. Livers were obtained from C3H/HeSFCI nu/+ males at 6 weeks of age. Transplantable DMBA-induced mammary tumors of the BALB/cCRGL strain, designated D1-DMBA-3 and D1-DMBA-4 (11), were a gift from D. Lopez (University of Miami). Livers were obtained from young BALB/cCRGL females. The human breast carcinoma cell line, MCF-7 (12), was obtained from L. B. Chen (Sidney Farber Cancer Institute). Normal human embryo lung fibroblasts (IMR90 cells) (13) were obtained from J. Rheinwald (Sidney Farber Cancer Institute).
Transfection Assays. Tumor tissues, livers, and normal mammary glands were rapidly removed, minced, and homogenized in a Dounce homogenizer. DNAs were extracted from tumor tissues, cell suspensions, and mammary glands as described (14) . Livers were processed similarly, except that the initial Pronase digestion was omitted and the sodium dodecyl Proc. Nad Acad. Sci. USA 78 (1981) Fig. 1 illustrates the results of experiments in which DNAs were digested with EcoRI, which cleaves at one internal site in MMTV DNA (9) , and hybridized to [32P]DNA of a plasmid containing the 1.3-kilobase (kb) long terminal redundancy (LTR) of MMTV DNA cloned in plasmid pBR322 (18) . DNAs of each of the five MMTV-induced C3H mammary. tumors yielded MMTV DNA-containing EcoRI fragments that were not present in C3H liver DNA and thus represented integration sites of exogenous MMTV proviruses (Fig. 1) . The reduced intensity ofhybridization to some exogenous fragments compared to endogenous fragments in the tumor DNAs is consistent with each exogenous provirus being represented only once per cell genome and with the possibility that the tumors contain some normal tissue. In contrast to DNAs of the MMTV-induced tumors, DNAs ofNIH cells transformed by DNAs ofthese tumors yielded only the endogenous MMTV DNA-containing EcoRI fragments that were present in DNA of normal NIH.3T3 cells (Fig. 1) . Similar results were obtained when DNAs were digested with Pst I, which cleaves at multiple sites in MMTV DNA (9) , and when blots were hybridized with [32P]DNA prepared from a plasmid containing approximately the 3' one-third ofthe (21) . Because the activated cellular transforming genes detected by transfection of DNAs of lymphoid leukosis virus-induced tumors are not linked to viral LTR sequences and are not homologous to c-myc (3, 22) , it appears that at least two different cellular genes with potential oncogenic activity are activated by different mechanisms in tumors induced by these viruses. MMTV may be similarly involved in a stage of mammary carcinogenesis distinct from activation of the cellular transforming genes detected in the. present study.
The transforming genes of all five MMTV-induced tumors, the chemically induced D1-DMBA-4 tumor, and the MCF-7 human tumor cell line displayed identical patterns of susceptibility to seven restriction endonucleases: inactivation by Pvu II and Sac I, but not.by. BamHI, EcoRI, HindIII, Kpn I, and Xho I. In contrast, transforming activities ofDNAs ofthree NIH cell lines transformed by normal chicken DNA fragments were inactivated by either BamHI or HindIII (1); transforming activities of human/bladder carcinoma DNAs were inactivated by EcoRI, 'HindIII, and Kpn I (4); transforming activities of chemically transformed mouse fibroblast DNAs were inactivated by EcoRI and HindIII (20) ; and transforming activities ofavian lymphoma DNAs were inactivated by EcoRI, HindIII, and Xho I (unpublished observations). The results of restriction endonuclease analysis of the seven mammary carcinoma DNAs therefore indicate that the transforming genes activated, in these tumors are structurally similar to each other but distinct from previously described cellular transforming genes.
The probability of different genes yielding the same pattern of sensitivity to the restriction endonucleases used can be estimated by the Poisson distribution from the average cleavage frequency of these enzymes in total cellular DNA. BamHI, EcoRI, HindIII, Pvu II, Sac I, and Xho I cleave cellular DNAs at average intervals of approximately 4 kb, and Kpn I cleaves at average intervals of approximately 15 kb. Assuming a gene size of 4 kb, the probability of inactivation by BamHI, EcoRI, HindIII, Pvu II, SacI, or Xho I is 0.63, and the probability of inactivation by Kpn I is approximately 0.2. The probability of two different genes displaying the pattern observed for the mammary carcinoma'DNAs is therefore (0.37)4(0.63)2(0.8) = .0.006. The probability of all seven tumor DNAs displaying this pattern-by chance is (0.006)6 = 4 X 10-14. The maximal likelihood of two genes displaying the observed pattern by chance would occur if the gene size was 1.6 kb. In this case, the probability of all seven tumor DNAs displaying the pattern is ap-proximately . It thus appears that the same or closely related transforming genes were activated in all seven mammary carcinomas.
To determine whether the expected evolutionary divergence between human, and mouse genes was inconsistent with the identical pattern of sensitivity to seven restriction endonucleases observed for human and mouse mammary carcinoma DNAs, computer analysis of DNA sequences was used to compare the sensitivity of human and mouse j3-globin (23, 24) and K constant region (25) genes to cleavage by 18 six-base-recognition restriction endonucleases. In both gene pairs, 14 ofthese enzymes yielded the same pattern ofcleavage sensitivity for the human and mouse gene homologs. It is, therefore, not extraordinary to obtain an identical pattern of sensitivity to seven enzymes in homologous genes activated in human and mouse mammary carcinomas.
Activation of related transforming genes in mouse mammary carcinomas induced by both viral and chemical carcinogens and in a cell line derived from a spontaneous human mammary carcinoma suggests the possibility that specific transforming genes are activated in neoplasms of particular tissue types. Recent studies of Shilo and Weinberg (20) , indicating that the transforming genes activated in four chemically transformed lines of mouse fibroblasts were related to each other, are also consistent with this notion. One hypothesis suggested by these observations is that, in some differentiated cell types, only one or a few ofthe total number ofcellular genes with potential transforming activity are susceptible targets for mutations or DNA rearrangements resulting in transforming gene activation. Alternatively, the total set of genes with potential transforming activity might be susceptible targets for activation in differentiated cells, but the state of differentiation of some cell types might render the cells phenotypically sensitive to the effects of only one or a few ofthese genes. In either case, it appears reasonable to speculate that genes involved in transformation of particular differentiated cell types might be normally involved in growth control of those cells, but not in cells ofother differentiation pathways. Analysis of the normal functions of cellular transforming genes, and of the molecular events involved in transforming gene activation, may permit experimental evaluation ofthese hypotheses.
